TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive 2013 Appropriations: Additional Level of Grant Review Proposed As NIH Prepares For Cost Cutting March 30, 2012
TCL Archive Hammer Says President’s Science Advisory to Ask For FY 1985 Supplemental Appropriations for NCI March 1, 1985
